ICYMI: LA TIMES – VACCINE MAKER GOT $1 BILLION FROM TAXPAYERS. NOW IT’S BOOSTING DRUG PRICES
Sep 15, 2020
Brand Name Drug Maker AstraZeneca Aggressively Raised Prices In The Middle Of… Read More
© 2026 CSRXP- All Rights Reserved
ICYMI
ICYMI: STUDY SHOWS BIG PHARMA’S ANTI-COMPETITIVE GAMESMANSHIP COMES AT TREMENDOUS COST TO U.S. HEALTHCARE SYSTEM
Sep 14, 2020
Report Finds Just Five Instances Of Product Hopping Sticks Americans With $4.7… Read More
ICYMI: REPORT CONFIRMS REBATE RULE WOULD HIKE PREMIUMS, COST TAXPAYERS BILLIONS OF DOLLARS AND BOOST “DRUG COMPANY REVENUES”
Sep 8, 2020
Study Finds Rebates Negotiated By PBMs Reduce Rx Costs and Lower Premiums –… Read More
ICYMI: STAT NEWS – NEW POLL SHOWS WIDE SUPPORT FOR SEVERAL TRUMP DRUG PRICING REFORMS, BUT NOT REBATE CHANGES
Aug 28, 2020
Administration Should Shelve Rebate Rule That Would Increase Medicare… Read More
ICYMI: Big Pharma Must Suspend Summer Price Hikes Amid Historic Economic Uncertainty
Jun 23, 2020
Big Pharma Must Suspend Summer Price Hikes Amid Historic Economic Uncertainty… Read More
Big Pharma’s Price-Gouging and Anti-Competitive Tactics Drive Increased Rx Spending
Dec 13, 2019
CMS Report Demonstrates Impact of Out-of-Control Launch Prices and Tactics… Read More
ICYMI: Political Courage Needed to Deliver on Drug Prices
Nov 25, 2019
Political Courage Needed to Deliver on Drug Prices By Lauren Aronson Real… Read More
ICYMI: GALLUP FINDS NEARLY 58 MILLION AMERICANS UNABLE TO AFFORD THEIR PRESCRIPTION DRUGS, UP FOUR PERCENT FROM JANUARY
Nov 13, 2019
Nine in Ten Surveyed Adults Believe Rx Prices “Much Higher” Or “Somewhat… Read More
ICYMI: An Unprecedented Opportunity for Washington to Lower Drug Prices
Sep 25, 2019
An Unprecedented Opportunity for Washington to Lower Drug Prices Lauren… Read More
In Case You Missed It: Congress must capitalize on momentum to hold Big Pharma accountable
Jul 9, 2019
Lauren Aronson The Hill July 9, 2019 The American people are demanding that… Read More
ICYMI: The Atlantic – Big Pharma’s Go-To Defense of Soaring Drug Prices Doesn’t Add Up
Mar 30, 2019
Just how expensive do prescription drugs need to be to fund innovative… Read More
ICYMI: Lack Of Competition In Drug Market Drives Up Medicare & Medicaid Spending
Mar 18, 2019
In case you missed it, the Centers for Medicare and Medicaid Services (CMS)… Read More